Navigation Links
Waging War on Wrinkles: Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport - The Botox Alternative
Date:7/19/2009

Infini Cosmetic Associates in Scottsdale will carry Dysport™ the newly FDA approved wrinkle remover and rival to Botox®. Founder and Chief Surgeon, Dr. William Hall has performed thousands of injections over the last six years and trained many other professionals on Botox® and other injectable dermal fillers. Dr. Hall is very skilled in many of the advanced uses of Botox for: hyperhidrosis (excessive sweating) and nervous tics in the face, neck bands and wrinkles, chin creases and dimpling, lip lines, and lower facial shaping.

Scottsdale, AZ (PRWEB) July 19, 2009 -- Dr. William Hall, Founder and Chief Surgeon at Infini Cosmetic Associates in Scottsdale, announced that Infini Cosmetic Associates will carry Dysport™ the newly FDA approved wrinkle remover and rival to Botox®. Dr. Hall has performed thousands of injections over the last six years and trained many other professionals on Botox® and other injectable dermal fillers. Dr. Hall is very skilled in many of the advanced uses of Botox for: hyperhidrosis (excessive sweating) and nervous tics in the face, neck bands and wrinkles, chin creases and dimpling, lip lines, and lower facial shaping.

The arrival of Dysport™ into the U.S. aesthetics marketplace will no doubt increase competition between the two wrinkle treatments and multiply physician choices and cosmetic options within the same medical practice.

"This is a burgeoning industry and dermal fillers are very popular, so as doctors we are always being introduced to new products that compete with ones we already use - for example I use both Restylane® and Juvederm®," Hall stated. "I have used and trained with Botox® for years and patients love the results, I will offer Dysport™ too, but ultimately, the patients decide after they try both products and see the lasting results," Dr. Hall concluded.

Medicis, a dermal filler leader (known for their popular Restylane® and Perlane® facial fillers) will promote the Dysport™ brand as part of a U.S. sales agreement with the manufacturer, Ipsen. The addition of Dysport™ to their dermal filler arsenal positions Medic as a threatening opponent to the Allergan empire and their line of beauty treatments (Botox® and the Juvederm® - hyaluronic acid gel fillers).

BOTOX® Cosmetic is the solution for many wrinkles, which are actually creases that have been worn into the skin by making the same expression thousands of times. Hall explains - "expression lines" are often called frown lines, crow's feet, or forehead lines and appear due to the contraction of a muscle under the skin in that area. BOTOX® Cosmetic offers a much safer, less invasive option than cutting the muscle and provides more predictable and enhanced results. Some have called this unique therapy "a facelift in a bottle." Now, with Dysport™ there are more products to wage war on age.

Botox and dermal fillers produce long-lasting, amazing results. Visit http://www.infiniskin.com/Wrinkles.html to find out more about wrinkle restoration. For more information about Infini Cosmetic Associates, visit www.infiniskin.com to see photo galleries and the amazing special offers on Botox and dermal fillers. To set up a free consultation, call 480-946-7100.

###

Read the full story at http://www.prweb.com/releases/2009/07/prweb2655704.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. StructuRad Launches MacroLive(TM) with INFINITT and RamSoft at RSNA 2007
2. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
3. Management Consultancy Announces Inaugural Infinitive Championship Series
4. AutoGenomics INFINITI Analyzer Receives Artistic Design Award
5. Infinity Business Systems of Tampa Expands Into Sarasota / Bradenton
6. Thank You, Dunder Mifflin Infinity
7. Infinity Property and Casualty Corporation Declares Quarterly Dividend
8. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
9. ProStor InfiniVault-DICOM Storage System Debuts in Rorke Data Booth at RSNA
10. Shaklee Hits the Road With Its Infinite Possibilities Tour
11. Shaklee Hits the Road with its Infinite Possibilities Tour in New York, NY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... The Incentive Research Foundation ... A Nudge Guide," a groundbreaking analysis of how behavioral economics can be applied ... immediately to IRR programs, the report highlights proven behavioral economics approaches and the ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, ... the heels of Thinksport’s award-winning sunscreen they’ve used the same scientific approach to ... , Countless deodorants flood the aisles that contain harmful chemicals that should be ...
(Date:4/27/2017)... ... April 27, 2017 , ... Last night, ... CAREGiverSM of the Year for her extraordinary compassion and lifelong dedication to serve ... American professional caregivers for the prestigious award each year – identifying a CAREGiver ...
(Date:4/27/2017)... ... April 27, 2017 , ... Goodcents Deli Fresh Subs announced a franchise ... area this year. , The first new location will open at the corner ... at 84th and Northern Lights Drive this fall. And the third location is in ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Are you ... tragic spike in water-related accidents and drownings during the summer. While most of us ... that these situations occur every day. Very few people are taking the time to ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
(Date:4/18/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 6.35% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical ... ("Precision Lens"), today announced the signing of a ... Precision Lens will deploy a dedicated sales team ... in the U.S., primarily focused in 13 states ...
Breaking Medicine Technology: